Wire report
Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs say
Health service has given US tech firm ‘unlimited access’ to certain data to build integrated platform, according to reports UK politics live – latest updates MPs have warned that an NHS decision to grant Palantir access to identifiable patient information in its plan to use AI to improve the health service is “dangerous” and will fuel public fears that data privacy is not being prioritised. NHS England has allowed staff from the US tech firm and other contractors to access patient data before it has been pseudonymised, despite internal fears of a “risk of loss of public confidence”, the Financial Times reported. Continue reading...

coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
Health service has given US tech firm ‘unlimited access’ to certain data to build integrated platform, according to reports UK politics live – latest updates MPs have warned that an NHS decision to grant Palantir access to identifiable patient information in its plan to use AI to improve the health service is “dangerous” and will fuel public fears that data privacy is not being prioritised. NHS England has allowed staff from the US tech firm and other contractors to access patient data before it has been pseudonymised, despite internal fears of a “risk of loss of public confidence”, the Financial Times reported. Continue reading...
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to The Guardian’s linked item, Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs say, Health service has given US tech firm ‘unlimited access’ to certain data to build integrated platform, according to reports UK politics live – latest updates MPs have warned that an NHS decision to grant Palantir access to identifiable patient information in its plan to use AI to improve the health service is “dangerous” and will fuel public fears that data privacy is not being prioritised. NHS England has allowed staff from the US tech firm and other contractors to access patient data before it has been pseudonymised, despite internal fears of a “risk of loss of public confidence”, the Financial Times reported. Continue reading…
Context
The development sits in VINI’s Technology coverage for readers following technology, science, product policy, markets, infrastructure, and the public consequences of innovation. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The linked item is dated 2026-05-11T12:01:26+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs say via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- Palantir’s access to identifiable NHS England patient data is ‘dangerous’, MPs sayThe Guardian - 2026-05-11T12:01:26+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.